Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Epigenetics-Based Therapeutics Market to Advance as Precision Oncology Research Expands" According to the latest report published by Data Bridge Market Research, the Epigenetics-Based Therapeutics Market CAGR Value The global epigenetics-based therapeutics market size was valued at USD 1.76 billion in 2024 and is expected to reach USD 5.17 billion by 2032, at a CAGR of 14.40% during the forecast period The Epigenetics-Based...0 Yorumlar 0 hisse senetleri 413 Views 0 önizleme
-
Global Post-CDK4/6 Treatment Line Oncology Drugs Market Report: Precision Oncology, Treatment Innovation and Growth ProspectsAccording to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market CAGR Value The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The...0 Yorumlar 0 hisse senetleri 447 Views 0 önizleme
-
How Is Demand for Precision Oncology Supporting the Asia-Pacific Tumor Ablation Market?According to the latest report published by Data Bridge Market Research, the Asia-Pacific Tumor Ablation Market CAGR Value The Asia-Pacific tumor ablation market size was valued at USD 2.36 billion in 2025 and is expected to reach USD 5.61 billion by 2033, at a CAGR of 11.45% during the forecast period The reliable Asia-Pacific Tumor Ablation Market research report includes...0 Yorumlar 0 hisse senetleri 397 Views 0 önizleme
-
Hyper Personalized Medicine Market Advances Through Precision Oncology ApplicationsThe global Hyper Personalized Medicine Market is rapidly evolving as emerging technologies enable healthcare providers to deliver highly targeted therapies tailored to individual biological characteristics. According to Polaris Market Research, the market reached USD 2,256.42 billion in 2023 and is forecast to grow to USD 6,333.03 billion by 2032, expanding at a CAGR of 12.2%. The increasing...0 Yorumlar 0 hisse senetleri 506 Views 0 önizleme
-
NUT Midline Carcinoma Treatment Market Outlook: Growing Adoption of Precision Medicine in OncologyThe NUT Midline Carcinoma Treatment Market is gaining attention as advancements in molecular diagnostics, targeted therapies, and precision oncology continue to transform the management of rare and aggressive cancers. NUT midline carcinoma (NMC) is an uncommon cancer caused primarily by genetic alterations involving the NUTM1 gene, leading to uncontrolled tumor growth. Due to its aggressive...0 Yorumlar 0 hisse senetleri 732 Views 0 önizleme
-
Oral HER Pathway Targeted Drugs Market Expands with Advances in Precision Oncology" According to the latest report published by Data Bridge Market Research, the Oral HER Pathway Targeted Drugs Market CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period The reliable Oral HER...0 Yorumlar 0 hisse senetleri 395 Views 0 önizleme
-
Radiation Oncology Treatment Planning Software Market Advances With Demand for Precision Cancer Care" According to the latest report published by Data Bridge Market Research, the Radiation Oncology Treatment Planning Software Market CAGR Value Data Bridge Market Research analyses that the radiation oncology treatment planning software market which was USD 2.18 billion in 2022, would rocket up to USD 4.34 billion by 2030, and is expected to undergo a CAGR of 9.00% during the...0 Yorumlar 0 hisse senetleri 194 Views 0 önizleme
-
Why Is Precision Oncology Driving the North America Prostate Cancer Diagnostics Market?According to the latest report published by Data Bridge Market Research, the North America Prostate Cancer Diagnostics Market CAGR Value The North America prostate cancer diagnostics market size was valued at USD 2.53 billion in 2024 and is expected to reach USD 6.67 billion by 2032, at a CAGR of 12.90% during the forecast period Winning North America Prostate Cancer Diagnostics...0 Yorumlar 0 hisse senetleri 230 Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek